Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-040663
Filing Date
2023-08-09
Accepted
2023-08-09 16:31:19
Documents
64
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q harp-20230630.htm   iXBRL 10-Q 3440369
2 EX-31.1 harp-ex31_1.htm EX-31.1 15064
3 EX-31.2 harp-ex31_2.htm EX-31.2 15055
4 EX-32.1 harp-ex32_1.htm EX-32.1 13076
  Complete submission text file 0000950170-23-040663.txt   11114578

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT harp-20230630_def.xml EX-101.DEF 196615
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT harp-20230630_pre.xml EX-101.PRE 335995
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT harp-20230630_cal.xml EX-101.CAL 45628
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT harp-20230630_lab.xml EX-101.LAB 467585
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT harp-20230630.xsd EX-101.SCH 56987
58 EXTRACTED XBRL INSTANCE DOCUMENT harp-20230630_htm.xml XML 2214092
Mailing Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080 (650) 443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

EIN.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38800 | Film No.: 231155699
SIC: 2836 Biological Products, (No Diagnostic Substances)